5 results displayed, search above for a specific certificate Request a Certificate Safety Data Sheets SDS Product Information Thermo Scientific™ Xpect™ Flu A & B Test Annual Analytical Reactivity Testing Data 2024 Thermo Scientific™ Xpect™ Flu A & B Test Annual Analytical Reactivity Testing...
The Panbio COVID-19/Flu A&B Panel (Abbott) is an in vitro diagnostic rapid test designed for the qualitative detection of nucleocapsid proteins SARS-CoV-2 and nucleoprotein influenza A and B antigens in nasal mid-turbinate (NMT) swab specimens from symptomatic individuals meeting COVID-19 and...
Influenza type C differs from types A and B in some important ways. Type C infection usually causes either a very mild respiratory illness or no symptoms at all. It does not cause epidemics and does not have the severe public health impact of influenza types A and B. Efforts to control ...
Influenza vaccines contain Influenza A and B antigens and are adjusted annually to match the characteristics of circulating viruses. In Germany, Influenza B viruses belonged to the B/Yamagata lineage, but since 2001, the antigenically distinct B/Victoria lineage has been co-circulating. Trivalent inf...
INFLUENZA A virus, H5N1 subtypeH7N9 InfluenzaAVIAN influenzaZIKA Virus Epidemic, 2015-2016VIRAL transmissionSERVICE dogsThis document discusses the potential impact of avian influenza H5N1 on competitive athletes and provides information on the virus, its transmission, and preventive measur...
2024-2025 Formula Initial U.S. Approval: 2013 Indications and Usage for Fluzone Quadrivalent Fluzone Quadrivalent is a vaccine indicated for active immunization for the prevention of disease caused by influenza A subtype viruses and type B viruses contained in the vaccine. (1) Fluzone Quadrivalen...
Sanofi offers a range of trivalent flu vaccines that help provide active immunization to prevent disease caused by influenza A subtype & type B virus. Please see Important Safety Information or Prescribing Information.
今秋接种三价流感疫苗足以 | 世界卫生组织(WHO)于2024年9月23-26日召开了2025年南半球流感疫苗组分会议,经过对全球流感病毒流行病学、病原学及疫苗血清学分析,推荐了2025年南半球流感疫苗组分。并且提出:自2020年3月以来,未再检测到自然存在的B/Yamagata系病毒,这表明B/Yamagata系病毒感染的风险极低。与以往的建议...
2024–2025 FormulaInitial U.S. Approval: 2009 Indications and Usage for Fluzone High-Dose Fluzone High-Dose is a vaccine indicated for active immunization for the prevention of disease caused by influenza A subtype viruses and type B virus contained in the vaccine. (1) Fluzone High-Dose ...
December 19, 2024 · 1 min read · Annalee Armstrong Manufacturing Novo Deepens Denmark Commitment With $1.2B Rare Disease Production Facility December 16, 2024 · 2 min read · Tristan Manalac Mergers & acquisitions Novo Holdings Gets FTC’s Go...